UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial

Diabetes care, 2018-02, Vol.41 (2), p.258-266

2018

Volltextzugriff (PDF)

Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline

The journal of clinical endocrinology and metabolism, 2016-11, Vol.101 (11), p.3922-3937

2016

Volltextzugriff (PDF)

Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry

Diabetes care, 2014-10, Vol.37 (10), p.2702-2709

2014

Volltextzugriff (PDF)

Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetes

Diabetes care, 2015-03, Vol.38 (3), p.476-481

2015

Volltextzugriff (PDF)

Comparison of Insulin Glargine 300 Units/mL and 100 Units/mL in Adults With Type 1 Diabetes: Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections

Diabetes care, 2017-04, Vol.40 (4), p.554-560

2017

Volltextzugriff (PDF)

REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes

Diabetes care, 2017-04, Vol.40 (4), p.538-545

2017

Volltextzugriff (PDF)

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP)

Diabetes technology & therapeutics, 2013-03, Vol.15 (3), p.198-211

2013

Volltextzugriff (PDF)

Advancing Insulin Therapy in Type 2 Diabetes Previously Treated With Glargine Plus Oral Agents: Prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy

Diabetes care, 2008, Vol.31 (1), p.20-25

2008

Volltextzugriff (PDF)

Combination therapy in type 2 diabetes mellitus: adding empagliflozin to basal insulin

Drugs in Context, 2015-11, Vol.4 (4), p.212288-7

Ahmann, Andrew

2015

Volltextzugriff (PDF)

Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes

Diabetes care, 2016-04, Vol.39 (4), p.603-610

2016

Volltextzugriff (PDF)

Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study

Diabetes care, 2016-02, Vol.39 (2), p.264-270

2016

Volltextzugriff (PDF)

Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes

Diabetes technology & therapeutics, 2022-06, Vol.24 (6), p.424-434

2022

Volltextzugriff (PDF)

Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial

The lancet. Diabetes & endocrinology, 2017-09, Vol.5 (9), p.700-708

2017

Volltextzugriff (PDF)

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes

Journal of the Endocrine Society, 2017-12, Vol.1 (12), p.1445-1460

2017

Volltextzugriff (PDF)

Approach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults

Journal of the Endocrine Society, 2018-12, Vol.2 (12), p.1320-1337

2018

Volltextzugriff (PDF)

Can trained dogs detect a hypoglycemic scent in patients with type 1 diabetes?

Diabetes care, 2013-07, Vol.36 (7), p.e98-e99

2013

Volltextzugriff (PDF)

Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensor

Diabetes technology & therapeutics, 2014-05, Vol.16 (5), p.277-283

2014

Volltextzugriff (PDF)

Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study

Diabetes technology & therapeutics, 2015-08, Vol.17 (8), p.542-547

2015

Volltextzugriff (PDF)

Advances in Glucose Monitoring and Automated Insulin Delivery: Supplement to Endocrine Society Clinical Practice Guidelines

Journal of the Endocrine Society, 2018-11, Vol.2 (11), p.1214-1225

2018

Volltextzugriff (PDF)

Safety Profile and Metabolic Effects of 14 Days of Treatment with DIO-902: Results of a Phase IIa Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial in Patients with Type 2 Diabetes Mellitus

Clinical therapeutics, 2008-06, Vol.30 (6), p.1081-1088

2008

Volltextzugriff (PDF)

Response to comment on Wong et al. Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry. Diabetes Care 2014;37:2702-2709

Diabetes care, 2015-04, Vol.38 (4), p.e61-e61

2015

Volltextzugriff (PDF)

Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring

Diabetes technology & therapeutics, 2021-03, Vol.23 (S1), p.S27-S-34

2021

Volltextzugriff (PDF)

Baseline predictors of A1C reduction in adults using sensor-augmented pump therapy or multiple daily injection therapy: the STAR 3 experience

Diabetes technology & therapeutics, 2011-06, Vol.13 (6), p.601-606

2011

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Aktive Filter

KollektionPublisher website

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(81)

Sprache

Englisch
(80)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(52)
Life Sciences & Biomedicine
(51)
Science & Technology
(51)
Endocrinology & Metabolism
(45)
Female
(36)
Male
(36)
Diabetes
(32)
Adult
(29)
Middle Aged
(27)
Aged
(19)
Diabetes Mellitus, Type 1 - Blood
(17)
Hypoglycemic Agents - Administration & Dosage
(16)
Insulin
(16)
Biological And Medical Sciences
(15)
Blood Glucose - Metabolism
(15)
Glucose
(15)
Adolescent
(13)
Hypoglycemic Agents - Therapeutic Use
(13)
Insulin - Administration & Dosage
(13)
Treatment Outcome
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial

Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline

Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry

Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetes

Comparison of Insulin Glargine 300 Units/mL and 100 Units/mL in Adults With Type 1 Diabetes: Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections

REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP)

Advancing Insulin Therapy in Type 2 Diabetes Previously Treated With Glargine Plus Oral Agents: Prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy

Combination therapy in type 2 diabetes mellitus: adding empagliflozin to basal insulin

Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes

Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study

Relationship Between Average Glucose Levels and HbA1c Differs Across Racial Groups: A Substudy of the GRADE Randomized Trial

Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes

Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes

Approach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults

Can trained dogs detect a hypoglycemic scent in patients with type 1 diabetes?

Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensor

Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study

Advances in Glucose Monitoring and Automated Insulin Delivery: Supplement to Endocrine Society Clinical Practice Guidelines

Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264-270

Safety Profile and Metabolic Effects of 14 Days of Treatment with DIO-902: Results of a Phase IIa Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial in Patients with Type 2 Diabetes Mellitus

Response to comment on Wong et al. Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry. Diabetes Care 2014;37:2702-2709

Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring

Baseline predictors of A1C reduction in adults using sensor-augmented pump therapy or multiple daily injection therapy: the STAR 3 experience

Aktive Filter

Suchergebnisse filtern